Sanna Lehtonen Selected Research

Sanna Lehtonen Research Topics

Disease

6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 12/2013
5	Insulin Resistance 01/2022 - 10/2010
5	Neoplasms (Cancer) 01/2020 - 03/2008
4	Type 2 Diabetes Mellitus (MODY) 12/2020 - 01/2019
4	Albuminuria 01/2018 - 08/2010
4	Nephrotic Syndrome (Syndrome, Nephrotic) 07/2005 - 06/2002
3	Obesity 01/2021 - 01/2016
3	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2015
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Proteinuria 01/2022 - 07/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2016 - 09/2015
1	Monosomy 01/2022
1	Hantavirus Infections 01/2022
1	Ischemia 01/2021
1	Flushing 01/2021
1	Hypertrophy 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Heart Failure 05/2017
1	Renal Insufficiency (Renal Failure) 01/2017
1	Myoma 05/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2016
1	congenital Nephrosis 03/2014
1	Necrosis 05/2012
1	Edema (Dropsy) 01/2012
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 07/2008
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2004
1	Carcinoma (Carcinomatosis) 01/2004
1	Autosomal Dominant Polycystic Kidney (ADPKD) 10/2002

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2002
7	nephrinIBA 01/2017 - 06/2002
4	Insulin (Novolin)FDA Link 01/2022 - 10/2010
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2019
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 01/2015
3	LipidsIBA 01/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	Messenger RNA (mRNA)IBA 05/2012 - 01/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 01/2019
2	LipopolysaccharidesIBA 01/2021 - 02/2016
2	AdiponectinIBA 01/2021 - 01/2016
2	CD2-associated proteinIBA 01/2017 - 10/2002
2	AlbuminsIBA 01/2015 - 12/2013
1	Serine (L-Serine)FDA Link 01/2023
1	heparanaseIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Inositol Polyphosphate 5-PhosphatasesIBA 01/2022
1	ebselenIBA 01/2022
1	IceIBA 01/2021
1	ezrinIBA 01/2021
1	EndotoxinsIBA 01/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	CytokinesIBA 01/2021
1	AdipoRonIBA 01/2021
1	Adiponectin ReceptorsIBA 01/2021
1	CholesterolIBA 01/2020
1	G007-LKIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	TankyrasesIBA 01/2020
1	Glycerolphosphate Dehydrogenase (Glycerol 3 Phosphate Dehydrogenase)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Insulin ReceptorIBA 01/2018
1	Myosins (Myosin)IBA 05/2017
1	3-phenyl-4,5-dihydro-5-isoxazole acetic acidIBA 05/2016
1	Cyclin-Dependent Kinase 2IBA 02/2016
1	Hormones (Hormone)IBA 01/2016
1	Pattern Recognition ReceptorsIBA 09/2015
1	ParaffinIBA 09/2015
1	Formaldehyde (Formol)FDA Link 09/2015
1	Blood Glucose (Blood Sugar)IBA 01/2015
1	Streptozocin (Streptozotocin)FDA Link 06/2014
1	MorpholinosIBA 01/2012
1	beta CateninIBA 08/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2010
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 07/2008
1	Vesicular Transport Adaptor ProteinsIBA 07/2008
1	LDL Receptors (LDL Receptor)IBA 07/2008
1	oxysterol binding proteinIBA 03/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2002

Therapy/Procedure

1	Kidney Transplantation 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2004